Former Scandinavian ChemoTech AB, has completed the name change to Neem's Hill AB ("Neem's Hill" or "the Company"), which was resolved at the Annual General Meeting held on 5 May 2026. The name change has been registered with the Swedish Companies Registration Office (Sw. Bolagsverket). As a result, the Company's ticker for trading on Nasdaq First North Growth Market will be changed to NEEMS as of 2026-07-13. The name change to Neem's Hill AB is part of the Company's strategic expansion of its existing business activities and will be implemented gradually to ensure consistency and clarity across all communication channels.
As previously communicated, this expansion aims to: (i) broaden the Company's service offering within veterinary and human medicine sectors through specialized consulting services in business development and organization; (ii) create opportunities for and facilitate strategic partnerships; and (iii) strengthen the Company's position by diversifying its revenue streams through consulting services and asset management activities, whilst maintaining its core expertise in medical technology development.
The strategic expansion, including the new name and visual identity, will be implemented gradually across all corporate platforms. The name change to Neem's Hill AB entails new trading designation and short name for the Company's share admitted to trading on Nasdaq First North Growth Market. The change will take effect as of 2026-07-13, as follows:
In connection with these changes taking effect, the Company will also launch a new website at www.neemshill.com.
The Company's registration number, VAT number, postal and visiting address remain unchanged.